A grave warning has been issued by global health authorities. Two months following the confirmation of the Ebola epidemic in the Democratic Republic of Congo, official figures released on July 15 indicate over 2,000 cases, tragically resulting in 796 fatalities. However, experts within the organization suggest the true number of infected individuals could be two to four times higher than currently reported. What factors contribute to this significant disparity? What makes this particular Ebola outbreak so challenging to contain? Can the recent launch of a groundbreaking post-exposure prophylaxis clinical trial, initiated this week in Bunia, shift the trajectory of this crisis?